PMID: 8597444Dec 29, 1995Paper

Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs

Annals of the New York Academy of Sciences
P W GoldG P Chrousos

Abstract

Hypercortisolism in depression seems to preferentially reflect activation of hypothalamic CRH secretion. Although it has been postulated that this hypercortisolism is an epiphenomenon of the pain and stress of major depression, our data showing preferential participation of AVP in the hypercortisolism of chronic inflammatory disease suggest specificity for the pathophysiology of hypercortisolism in depression. Our findings that imipramine causes a down-regulation of the HPA axis in experimental animals and healthy controls support an intrinsic role for CRH in the pathophysiology of melancholia and in the mechanism of action of psychotropic agents. Our data suggest that hypercortisolism is not the only form of HPA dysregulation in major depression. In a series of studies, commencing in patients with Cushing's disease, and extending to hyperimmune fatigue states such as chronic fatigue syndrome and examples of atypical depression such as seasonal affective disorder, we have advanced data suggesting hypofunction of hypothalamic CRH neurons. These data raise the question that the hyperphagia, hypersomnia, and fatigue associated with syndromes of atypical depression could reflect a central deficiency of a potent arousal-producing an...Continue Reading

References

Feb 1, 1976·Psychological Medicine·B J CarrollA A Sugerman
Nov 15, 1992·Annals of Internal Medicine·E M SternbergP W Gold
Dec 1, 1991·The Journal of Clinical Endocrinology and Metabolism·M A DemitrackP W Gold
Mar 1, 1989·The American Journal of Psychiatry·R G KatholW H Meller
Jun 1, 1988·Archives of General Psychiatry·C B NemeroffM Stanley
Sep 1, 1985·The American Journal of Psychiatry·L J Siever, K L Davis
Jul 1, 1987·The Journal of Clinical Endocrinology and Metabolism·P C AvgerinosG P Chrousos
Aug 18, 1988·The New England Journal of Medicine·P W GoldG P Chrousos
Jan 1, 1988·Advances in Experimental Medicine and Biology·D RabinG P Chrousos
Aug 11, 1988·The New England Journal of Medicine·P W GoldG P Chrousos
May 1, 1987·The American Journal of Psychiatry·A RoyP W Gold
Oct 1, 1970·Archives of General Psychiatry·E J SacharT F Gallagher
Nov 1, 1982·The Journal of Clinical Endocrinology and Metabolism·H M SchulteD L Loriaux
Oct 1, 1983·The Journal of Clinical Endocrinology and Metabolism·D L HealyG D Hodgen
May 1, 1984·The American Journal of Psychiatry·P W GoldD L Loriaux
Jun 1, 1984·The Journal of Clinical Endocrinology and Metabolism·H M SchulteD L Loriaux
Jan 1, 1984·The Journal of Clinical Endocrinology and Metabolism·H M SchulteD L Loriaux

❮ Previous
Next ❯

Citations

Apr 25, 2006·Experimental Brain Research·Henry J MollerColin M Shapiro
Feb 23, 2010·European Archives of Psychiatry and Clinical Neuroscience·Maurizio PompiliDavid Lester
Nov 28, 2007·Archives of Women's Mental Health·E Sibolboro Mezzacappa, J Endicott
Feb 4, 2011·Clinical Child and Family Psychology Review·John D Guerry, Paul D Hastings
Jun 18, 2005·Psychoneuroendocrinology·Heather M BurkeDavid C Mohr
Mar 18, 1999·Pharmacology, Biochemistry, and Behavior·A SattinR L Lloyd
Jul 14, 1999·Journal of Affective Disorders·L V ScottT G Dinan
Mar 31, 1999·Psychoneuroendocrinology·A V RavindranH Anisman
Oct 29, 2002·Brain, Behavior, and Immunity·H Anisman, Z Merali
Sep 27, 2001·Endocrinology and Metabolism Clinics of North America·K E HabibG P Chrousos
Jul 4, 1997·Psychiatry Research·P J SchwartzN E Rosenthal
Aug 21, 2003·Bioorganic & Medicinal Chemistry·Paul J GilliganWilliam J Marshall
Apr 2, 2005·Journal of the International Neuropsychological Society : JINS·Ramona O HopkinsJames F Orme
Aug 16, 2002·Bipolar Disorders·Carrol D'Sa, Ronald S Duman
Sep 29, 2011·Nature Reviews. Endocrinology·Andrew S Papadopoulos, Anthony J Cleare
Dec 3, 1999·Journal of Internal Medicine·B EvengårdA L Komaroff
Mar 5, 2004·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Natalie Rasgon, Lissy Jarvik
Jul 18, 2003·Harvard Review of Psychiatry·Michael A Posternak
Nov 16, 2004·American Journal of Respiratory and Critical Care Medicine·Ramona O HopkinsJames F Orme
Jan 12, 2012·PloS One·Giovanni CizzaUNKNOWN P.O.W.E.R. (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group
Nov 28, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lynn G KirbySheryl G Beck
Oct 16, 2014·Pharmacology, Biochemistry, and Behavior·Priscila B RosaAna Lúcia S Rodrigues
Jul 9, 2011·Neuropharmacology·Thomas Steckler, Victoria Risbrough
Mar 23, 2010·General Hospital Psychiatry·Ramona O HopkinsJames F Orme
Mar 10, 2009·Sleep Medicine Reviews·Katherine A Kaplan, Allison G Harvey
Mar 11, 2009·Psychoneuroendocrinology·Kathryn P Brooks, Theodore F Robles

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.